{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:21:41Z","timestamp":1768530101469,"version":"3.49.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010377","name":"National Institute for Health and Care Excellence","doi-asserted-by":"publisher","award":["EACFA18-21"],"award-info":[{"award-number":["EACFA18-21"]}],"id":[{"id":"10.13039\/100010377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Aims<\/jats:title>\n<jats:p>PFO closure is a percutaneous intervention, which aims to reduce risk of recurrent stroke by preventing paradoxical embolism. The objective of this study was to measure procedural safety and longer-term effectiveness of PFO closure in a UK setting.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and results<\/jats:title>\n<jats:p>Prospective registry data from patients with cryptogenic stroke eligible for PFO closure were collected for up to 2 years and linked to routine data sources for additional follow-up. Outcomes of interest included procedural success rate, health related quality of life, and longer-term death and neurological event rates.<\/jats:p>\n<jats:p>A total of 973 PFO closure procedures in 971 patients were included in analysis. Successful device implantation was achieved in 99.4 [95% CI 98.6 to 99.8]% of procedures, with one in-hospital death. During median follow-up of 758 (Q1:Q3 527:968) days, 33 patients experienced a subsequent neurological event, 76% of which were ischaemic in origin. Neurological event rate was 2.7 [95%CI 1.6 to 3.9]% at 1-year (n = 751) and 4.1 [95% CI 2.6 to 5.5]% at 2-years (n = 463) using Kaplan-Meier analysis. Improvements in patient quality of life (utility and visual analogue scale) were observed at 6-weeks and 6-months follow-up.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our observational study demonstrates that PFO closure for prevention of recurrent stroke is a relatively safe procedure but in routine clinical practice is associated with a slightly higher risk of recurrent neurological events than in randomised trials. We hypothesize that our study enrolled unselected patients with higher baseline risk, who were excluded from randomised trials, but who may benefit from a similar relative reduction in risk from the intervention.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0271117","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:39:37Z","timestamp":1657820377000},"page":"e0271117","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Patent foramen ovale closure: A prospective UK registry linked to hospital episode statistics"],"prefix":"10.1371","volume":"17","author":[{"given":"Iain","family":"Willits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-6279","authenticated-orcid":true,"given":"Kim","family":"Keltie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-3691","authenticated-orcid":true,"given":"Robert","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-8319","authenticated-orcid":true,"given":"Mark","family":"de Belder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Linker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-9699","authenticated-orcid":true,"given":"Lee","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Urwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3036-3374","authenticated-orcid":true,"given":"Helen","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-7278","authenticated-orcid":true,"given":"Andrew J.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"pone.0271117.ref001","unstructured":"National Institute for Health and Care Excellence. NICEimpact stroke. National Institute for Health and Care Excellence; 2019. https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/Into-practice\/measuring-uptake\/NICE-Impact-stroke.pdf"},{"key":"pone.0271117.ref002","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/heartjnl-2015-307516","article-title":"The epidemiology of cardiovascular disease in the UK 2014","volume":"101","author":"P Bhatnagar","year":"2015","journal-title":"Heart"},{"key":"pone.0271117.ref003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ageing\/afn281","article-title":"Cost of stroke in the United Kingdom","volume":"38","author":"\u00d6 Saka","year":"2009","journal-title":"Age and Ageing"},{"key":"pone.0271117.ref004","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct","volume":"13","author":"RG Hart","year":"2014","journal-title":"The Lancet Neurology"},{"key":"pone.0271117.ref005","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.104.524371","article-title":"Patent Foramen Ovale and Stroke","volume":"112","author":"S Homma","year":"2005","journal-title":"Circulation"},{"key":"pone.0271117.ref006","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","article-title":"Patent Foramen Ovale in Cryptogenic Stroke","volume":"40","author":"AA Alsheikh-Ali","year":"2009","journal-title":"Stroke"},{"key":"pone.0271117.ref007","article-title":"Anticoagulants versus antiplatelet agents for acute ischaemic stroke","author":"E Berge","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"pone.0271117.ref008","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jacc.2011.09.085","article-title":"Patent Foramen Ovale: The Known and the To Be Known","volume":"59","author":"S Kutty","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"pone.0271117.ref009","doi-asserted-by":"crossref","first-page":"129196","DOI":"10.1155\/2014\/129196","article-title":"Patent Foramen Ovale and Closure Technique with the Amplatzer Occluder","volume":"2014","author":"B. Meier","year":"2014","journal-title":"Scientifica"},{"key":"pone.0271117.ref010","doi-asserted-by":"crossref","first-page":"e008356","DOI":"10.1161\/JAHA.117.008356","article-title":"Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study","volume":"7","author":"G Turc","year":"2018","journal-title":"Journal of the American Heart Association"},{"key":"pone.0271117.ref011","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/WNL.0000000000009443","article-title":"Practice advisory update summary: Patent foramen ovale and secondary stroke prevention","volume":"94","author":"SR Mess\u00e9","year":"2020","journal-title":"Neurology"},{"key":"pone.0271117.ref012","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"J Vandenbroucke","year":"2007","journal-title":"PLoS Medicine"},{"key":"pone.0271117.ref013","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ehjqcco\/qcab042","article-title":"Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics","volume":"7","author":"I Willits","year":"2021","journal-title":"European Heart Journal\u2014Quality of Care and Clinical Outcomes"},{"key":"pone.0271117.ref014","unstructured":"Ray D, Roebuck C, Smith O. Linked datasets supporting health and care delivery and research. NHS Digital; 2018 Apr. https:\/\/digital.nhs.uk\/services\/data-access-request-service-dars\/linked-datasets-supporting-health-and-care-delivery-and-research"},{"key":"pone.0271117.ref015","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria; 2021. https:\/\/www.R-project.org\/"},{"key":"pone.0271117.ref016","unstructured":"NHS England. Clinical Commissioning Policy: Percutaneous patent foraman ovale closure for the prevention of recurrent cerebral embolic stroke in adults (around the age 60 years and under). NHS England; 2019 Jul. Report No.: NHS England Reference 170130P. https:\/\/www.england.nhs.uk\/commissioning\/publication\/percutaneous-patent-foraman-ovale-closure-for-the-prevention-of-recurrent-cerebral-embolic-stroke-in-adults-around-the-age-60-years-and-under\/"},{"key":"pone.0271117.ref017","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"L Friberg","year":"2012","journal-title":"European Heart Journal"},{"key":"pone.0271117.ref018","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"DM Kent","year":"2013","journal-title":"Neurology"},{"key":"pone.0271117.ref019","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1161\/STROKEAHA.120.029350","article-title":"Risk of Paradoxical Embolism (RoPE)\u2013Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure","volume":"51","author":"DM Kent","year":"2020","journal-title":"Stroke"},{"key":"pone.0271117.ref020","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke","volume":"368","author":"JD Carroll","year":"2013","journal-title":"N Engl J Med"},{"key":"pone.0271117.ref021","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke","volume":"377","author":"J-L Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0271117.ref022","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic Stroke and High-Risk Patent Foramen Ovale","volume":"71","author":"Pil H Lee","year":"2018","journal-title":"Journal of the American College of Cardiology"},{"key":"pone.0271117.ref023","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale","volume":"366","author":"AJ Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0271117.ref024","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism","volume":"368","author":"B Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"pone.0271117.ref025","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke","volume":"377","author":"L S\u00f8ndergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"pone.0271117.ref026","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jval.2016.11.015","article-title":"Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores","volume":"20","author":"NS McClure","year":"2017","journal-title":"Value in Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:40:04Z","timestamp":1657820404000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0271117"}},"subtitle":[],"editor":[{"given":"Tomohiko","family":"Ai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0271117","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]}}}